Union leads worker blockade of Sanofi plant

The General Confederation of Labour unions (CGT) in France led a Sanofi employee blockade of the drug giant's Romainville manufacturing plant earlier this week. The plant is used in API and drug production for antibiotics and corticosteroids.

The blockade protested plans announced for the plant's closure. The union said that the company's offer of reassignment to 80 of the plant's 170 employees was inadequate. Union officials said that Sanofi management had refused to consider proposals to continue operations at the site.

Sanofi announced early this month a restructuring expected to eliminate 25 percent of the work force in its 6,900-employee U.S. Pharmaceutical Operations, about 1,700 positions. Its intent is to shift resources to strategic treatment priorities, improve efficiency and simplify infrastructure.

- see the news from Boursier.com (translated by Google)
- see the Sanofi U.S. announcement

Suggested Articles

The FDA has found issues with the testing practices of a U.S. generics maker that had specific problems with ADHD and weight-loss drugs.

A warning letter says Chinese API maker Yibin Lihao Bio-technical was found lying to the FDA about manufacturing unapproved heparin.

It took four tries over four years, but Perrigo has finally gotten FDA approval of its generic of Teva’s tricky-to-make ProAir HFA asthma inhaler.